and 4 other(s)
Insulin intensification/titration is part of the standards of medical care in the treatment of diabetes. Despite acknowledgement that basal insulin requires titration, most people with type 2 diabetes (T2DM) are unsuccessful in achieving glycemic targets. Factors, including treatment inertia, are evident as the initial insulin dose often increases only slightly from date of initiation to six months. Consequently, there is a need for increasing healthcare providers’ awareness about insulin treatment inertia, as well as more effective, patient-centered titration strategies. The pharmacologic approaches to glycemic treatment call on patients to employ a self-titration insulin algorithm, as it has been shown to improve glycemic control in those with T2DM. A recent national survey indicated that over 80 percent of diabetes educators have influence over the use of technology, including apps & devices. Moreover, the same practitioners play a critical role in insulin initiation and influence insulin titration. There are many insulin titration options that include digital therapeutics. The purpose of this literature review is to examine the effectiveness and design of FDA-cleared insulin titration apps.
No datasets are available for this submission.
No license information is available for this submission.